← Eichor
Condition: Antiviral Drugs Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Antiviral Drugs

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Population Pharmacokinetics of Anti-infectives in Critically Ill Children
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT02539407Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
Phase N/A · 1 location(s) · VA Office of Research and Development · NCT06160128A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Phase 2 · 123 location(s) · ViiV Healthcare · NCT07202546Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infec
Phase 1/Phase 2 · 1 location(s) · LucasBio · NCT07670468Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study)
Phase 1 · 1 location(s) · Aarhus University Hospital · NCT06668727OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Tri
Phase 2 · 18 location(s) · ANRS, Emerging Infectious Diseases · NCT05587894LAssa Fever Adjunct Treatment With DEXamethasone
Phase 2 · 1 location(s) · Bernhard Nocht Institute for Tropical Medicine · NCT06222723A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2)
Phase 2/Phase 3 · 2 location(s) · Hyundai Bioscience Co., Ltd. · NCT07576868A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment
Phase 3 · 53 location(s) · Takeda · NCT05319353ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings
NA · 32 location(s) · Kirby Institute · NCT03685045Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus
Phase 1/Phase 2 · 19 location(s) · Gilead Sciences · NCT07096193A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza
Phase 2 · 4 location(s) · University of Oxford · NCT05648448Efficacy of Baloxavir Against Influenza in Hospitalized Patients: The INFLUENT Study (INpatients inFLUENza Treatment)
Phase 3 · 1 location(s) · Dre Pauline Vetter · NCT06653569Drug-Drug Intercations and Direct Acting Antiviral Agents Against HCV
Phase N/A · 4 location(s) · University of Seville · NCT06928259Decentralization of Hepatitis B Care in Sub-Saharan Africa: a Pilot Program in Ethiopia
Phase N/A · 1 location(s) · Oslo University Hospital · NCT06586983The Efficacy of Vosevi in Treating DAA-experienced Patients
Phase N/A · 1 location(s) · The Third Affiliated Hospital of Guangzhou Medical Universit · NCT06180590Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lu
Phase 4 · 1 location(s) · University Health Network, Toronto · NCT07235683A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and Wi
Phase 1 · 6 location(s) · BioNTech SE · NCT07392372Treatment and Prognosis of Patients With Chronic HBV Infection
Phase N/A · 1 location(s) · Xiangya Hospital of Central South University · NCT05392387Antiviral Clinical Trial for Long Covid-19
Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06511063Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Cent
NA · 1 location(s) · National Taiwan University Hospital · NCT07294547A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not H
Phase 3 · 248 location(s) · Pfizer · NCT06679140OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients
Phase 2 · 4 location(s) · Calmy Alexandra · NCT07406217A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants
Phase 3 · 18 location(s) · Shanghai Ark Biopharmaceutical Co., Ltd. · NCT06775405Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study
Phase 2 · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT07511049Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder
Phase 2/Phase 3 · 1 location(s) · White River Junction Veterans Affairs Medical Center · NCT05637879Antiviral Therapy for Patients With Liver Cancer After Surgery
Phase N/A · 1 location(s) · Xiangya Hospital of Central South University · NCT05466565Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B
Phase 1 · 4 location(s) · Precision BioSciences, Inc. · NCT06680232Treatment as Prevention for Hepatitis C in Iceland
Phase N/A · 1 location(s) · Landspitali University Hospital · NCT02647879Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir
Phase 4 · 4 location(s) · Mount Sinai Hospital, Canada · NCT06792214
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.